Related Experiment Video
Updated: Jun 18, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Understanding the Evolving Pathophysiology of Coronavirus Disease 2019 and Adult Nursing Management
Kathleen M Luckner1, Maureen A Seckel2
1ChristianaCare, 4755 Ogletown-Stanton Road, Newark, DE 19713, USA.
Insights
This summary covers the evolving understanding and management of Coronavirus disease 2019 (COVID-19). Key treatments include antivirals, immunomodulators, and anticoagulants, alongside supportive care for severe cases.
Area of Science:
- Infectious Diseases
- Immunology
- Critical Care Medicine
Background:
- Coronavirus disease 2019 (COVID-19) emerged in December 2019, rapidly escalating into a global pandemic.
- Understanding of COVID-19's pathophysiology, treatment, and management has significantly evolved since 2020.
- COVID-19 presents with potential complications including immune dysfunction, hypoxemic lung injury, acute kidney injury, and coagulopathy.
Purpose of the Study:
- To outline the current understanding of COVID-19 pathophysiology.
- To detail the evolving treatment and management strategies for COVID-19 based on disease severity.
- To highlight key therapeutic classes and supportive measures for managing COVID-19 patients.
Main Methods:
- Review of current medical literature and clinical guidelines.
- Analysis of disease progression from asymptomatic to severe, life-threatening presentations.
- Categorization of recommended pharmacological and supportive interventions.
Main Results:
- Treatment is stratified according to illness severity, from mild to critical.
- Three primary medication classes are recommended: antivirals, immunomodulators, and anticoagulants.
- Supportive therapies are crucial, including oxygenation, mechanical ventilation, and prone positioning.
Conclusions:
- Effective management of COVID-19 requires a multi-faceted approach tailored to individual patient needs.
- Antivirals, immunomodulators, and anticoagulants form the cornerstone of pharmacotherapy.
- Aggressive supportive care is essential for improving outcomes in severe COVID-19 cases.
Abstract:
Coronavirus disease 2019 (COVID-19) was first identified in December 2019 and quickly became a global pandemic. The understanding of the pathophysiology, treatment, and management of the disease has evolved since the beginning of the pandemic in 2020. COVID-19 can be complicated by immune system dysfunction, lung injury with hypoxemia, acute kidney injury, and coagulopathy. The treatment and management of COVID-19 is based on the severity of illness, ranging from asymptomatic to severe and often life-threatening disease. The 3 main recommended medication classes include antivirals, immunomodulators, and anticoagulants. Other supportive therapies include ensuring adequate oxygenation, mechanical ventilation, and prone positioning.
More Related Videos
09:02Infection of Primary Nasal Epithelial Cells Grown at an Air-Liquid Interface to Characterize Human Coronavirus-Host Interactions
Published on: September 22, 2023
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Asthma-IV: Nursing Management
First, in...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment